These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 27164293)

  • 1. IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY.
    Greer TL; Trombello JM; Rethorst CD; Carmody TJ; Jha MK; Liao A; Grannemann BD; Chambliss HO; Church TS; Trivedi MH
    Depress Anxiety; 2016 Sep; 33(9):870-81. PubMed ID: 27164293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
    Solvason HB; Husain M; Fitzgerald PB; Rosenquist P; McCall WV; Kimball J; Gilmer W; Demitrack MA; Lisanby SH
    Brain Stimul; 2014; 7(2):219-25. PubMed ID: 24332384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison.
    Trivedi MH; Greer TL; Church TS; Carmody TJ; Grannemann BD; Galper DI; Dunn AL; Earnest CP; Sunderajan P; Henley SS; Blair SN
    J Clin Psychiatry; 2011 May; 72(5):677-84. PubMed ID: 21658349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
    Conway CR; Kumar A; Xiong W; Bunker M; Aaronson ST; Rush AJ
    J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30152645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Breathing-Based Meditation Intervention for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study.
    Sharma A; Barrett MS; Cucchiara AJ; Gooneratne NS; Thase ME
    J Clin Psychiatry; 2017 Jan; 78(1):e59-e63. PubMed ID: 27898207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiological mechanisms of exercise and psychotherapy in depression: The SPeED study-Rationale, design, and methodological issues.
    Heinzel S; Rapp MA; Fydrich T; Ströhle A; Terán C; Kallies G; Schwefel M; Heissel A
    Clin Trials; 2018 Feb; 15(1):53-64. PubMed ID: 28905640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.
    Morton E; Bhat V; Giacobbe P; Lou W; Michalak EE; McInerney S; Chakrabarty T; Frey BN; Milev RV; Müller DJ; Parikh SV; Rotzinger S; Kennedy SH; Lam RW;
    CNS Drugs; 2021 Apr; 35(4):439-450. PubMed ID: 33860922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
    Hirschfeld RM; Dunner DL; Keitner G; Klein DN; Koran LM; Kornstein SG; Markowitz JC; Miller I; Nemeroff CB; Ninan PT; Rush AJ; Schatzberg AF; Thase ME; Trivedi MH; Borian FE; Crits-Christoph P; Keller MB
    Biol Psychiatry; 2002 Jan; 51(2):123-33. PubMed ID: 11822991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial functioning in patients with Treatment-Resistant Depression after group cognitive behavioral therapy.
    Matsunaga M; Okamoto Y; Suzuki S; Kinoshita A; Yoshimura S; Yoshino A; Kunisato Y; Yamawaki S
    BMC Psychiatry; 2010 Mar; 10():22. PubMed ID: 20230649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial aspects of resistance in complex treatment of depressive disorder.
    Sedlackova Z; Prasko J; Latalova K; Kamaradova D; Ociskova M; Grambal A; Sigmundova Z; Kasalova P; Cakirpaloglu S
    Neuro Endocrinol Lett; 2015; 36(4):354-62. PubMed ID: 26454491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients with Major Depressive Disorder: A Preliminary Randomized Controlled Trial.
    Shachar-Malach T; Cooper Kazaz R; Constantini N; Lifschytz T; Lerer B
    Isr J Psychiatry Relat Sci; 2015; 52(3):65-70. PubMed ID: 27357556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent changes in cognitive function with exercise augmentation for major depression: results from the TREAD study.
    Greer TL; Grannemann BD; Chansard M; Karim AI; Trivedi MH
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):248-56. PubMed ID: 25453481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder.
    Caliyurt O; Guducu F
    J Affect Disord; 2005 Sep; 88(1):75-8. PubMed ID: 15967511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study.
    DiBernardo A; Lin X; Zhang Q; Xiang J; Lu L; Jamieson C; Benson C; Lee K; Bodén R; Brandt L; Brenner P; Reutfors J; Li G
    BMC Psychiatry; 2018 Oct; 18(1):352. PubMed ID: 30373547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in quality of life outcomes among depressed spinal cord injury trial participants.
    Tate DG; Forchheimer M; Bombardier CH; Heinemann AW; Neumann HD; Fann JR
    Arch Phys Med Rehabil; 2015 Feb; 96(2):340-8. PubMed ID: 25450124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.
    Rethorst CD; Toups MS; Greer TL; Nakonezny PA; Carmody TJ; Grannemann BD; Huebinger RM; Barber RC; Trivedi MH
    Mol Psychiatry; 2013 Oct; 18(10):1119-24. PubMed ID: 22925832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relief of depression and pain improves daily functioning and quality of life in patients with major depressive disorder.
    Lin CH; Yen YC; Chen MC; Chen CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():93-8. PubMed ID: 23989033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpersonal psychotherapy as add-on for treatment-resistant depression: A pragmatic randomized controlled trial.
    Souza LH; Salum GA; Mosqueiro BP; Caldieraro MA; Guerra TA; Fleck MP
    J Affect Disord; 2016 Mar; 193():373-80. PubMed ID: 26799332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.